Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 18.6B | 16.7B | 17.1B | 17.4B |
Cost of revenue | 9.7B | 8.6B | 8.7B | 9.0B |
Gross profit | 9.0B | 8.1B | 8.4B | 8.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.1B | 3.7B | 3.9B | 3.9B |
Operating income | 1.6B | 1.1B | 1.3B | 1.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 26M | 346.6M | 463.9M | 465.3M |
Other income expense | — | — | — | — |
Pretax income | 1.7B | 1.0B | 990.7M | 1.0B |
Tax provision | 382.9M | 216.8M | 157.5M | 281M |
Net income | 1.3B | 801M | 833.2M | 738.9M |
Basic EPS | — | 0.2 | 0.2 | 0.2 |
Diluted EPS | — | 0.2 | 0.2 | 0.2 |
Basic average shares | — | 5.3B | 4.9B | 4.9B |
Diluted average shares | — | 5.3B | 4.9B | 4.9B |
EBITDA | 2.6B | 2.3B | 2.4B | 2.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | -1.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |